Bixiye
QP83-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Egrifta® (tesamorelin)
Taariikhda uu dhaqangalayo barnaamijka: Okt 23, 2019
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2531 - 2540 ee natiijooyinka 3167
Bixiye
QP84-19 Skilled Nursing Facility (SNF) Billing
Taariikhda uu dhaqangalayo barnaamijka: Okt 23, 2019
Bixiye
QP80-19 Pharmacy Benefit Exclusion for ProAir®Digihaler™
Taariikhda uu dhaqangalayo barnaamijka: Okt 09, 2019
Bixiye
QP81-19 Pharmacy Benefit Exclusion for Pazeo®, Bepreve®, and Rasuvo®
Taariikhda uu dhaqangalayo barnaamijka: Okt 09, 2019
Bixiye
QP79-19 Blue Cross Introduces a New and Easier Way to Find Medical Policies
Taariikhda uu dhaqangalayo barnaamijka: Okt 09, 2019
Bixiye
P23R1-19 Alignment of Start Date for Prior Authorization Requests
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2019
Bixiye
2019 October Bulletins
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2019
Bixiye
P72-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates- Effective December 2, 2019
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2019
Bixiye
P75-19 Identified Global Claims Issues Grids
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2019
Bixiye
P71R1-19 Update: Attachments for Minnesota Health Care Programs (MHCP) Claims
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2019